Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-23

Clinical Trial Update: Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC [Phase 4]

View source ↗

Summary

Phase 4 trial investigating cipterbin combined with vinorelbine for metastatic breast cancer is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cipterbin
  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Metastatic Breast Cancer | Phase 4 | Status: UNKNOWN